ASX - By Stock
|
AGN |
Re:
Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
|
|
Lachietrades
|
22 |
6.3K |
2 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
22
|
6.3K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
|
|
Lachietrades
|
22 |
6.3K |
0 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
22
|
6.3K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
|
|
Lachietrades
|
22 |
6.3K |
3 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
22
|
6.3K
|
3
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
9 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
140K
|
53M
|
9
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
21 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
140K
|
53M
|
21
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
4 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
140K
|
53M
|
4
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
22 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
140K
|
53M
|
22
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Awarded $1.2m CRC-P Grant for TBI Project
|
|
Lachietrades
|
12 |
3.7K |
1 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
12
|
3.7K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Successful Completion of Phase 1 Clinical Trial Dosing
|
|
Lachietrades
|
41 |
11K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
41
|
11K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Successful Completion of Phase 1 Clinical Trial Dosing
|
|
Lachietrades
|
41 |
11K |
0 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
41
|
11K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Successful Completion of Phase 1 Clinical Trial Dosing
|
|
Lachietrades
|
41 |
11K |
5 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
41
|
11K
|
5
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
29 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
140K
|
53M
|
29
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
2 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
140K
|
53M
|
2
|
|
ASX - By Stock
|
SYA |
Re:
THE ASX IS BROKEN
|
|
Lachietrades
|
40 |
22K |
8 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
40
|
22K
|
8
|
|
ASX - By Stock
|
AGN |
Re:
Ann: SRC Approves Commencement Of Fourth And Final Cohort Dosing
|
|
Lachietrades
|
12 |
3.1K |
3 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
12
|
3.1K
|
3
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
3 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
140K
|
53M
|
3
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
9 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
140K
|
53M
|
9
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
0 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
140K
|
53M
|
0
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
1 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
140K
|
53M
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 1 Clinical Trial Progress Update
|
|
Lachietrades
|
15 |
3.9K |
3 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
15
|
3.9K
|
3
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
8 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
140K
|
53M
|
8
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
10 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
140K
|
53M
|
10
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
4 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
140K
|
53M
|
4
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
5 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
140K
|
53M
|
5
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
28 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
140K
|
53M
|
28
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
11 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
140K
|
53M
|
11
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
0 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
140K
|
53M
|
0
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
140K
|
53M
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
2 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
140K
|
53M
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Safety Review Committee Approves Third Cohort Commencement
|
|
Lachietrades
|
17 |
4.1K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
17
|
4.1K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Safety Review Committee Approves Third Cohort Commencement
|
|
Lachietrades
|
17 |
4.1K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
17
|
4.1K
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
6 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
140K
|
53M
|
6
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
13 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
140K
|
53M
|
13
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Safety Review Committee Approves Third Cohort Commencement
|
|
Lachietrades
|
17 |
4.1K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
17
|
4.1K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Safety Review Committee Approves Third Cohort Commencement
|
|
Lachietrades
|
17 |
4.1K |
1 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
17
|
4.1K
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
1 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
140K
|
53M
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
8 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
140K
|
53M
|
8
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
2 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
140K
|
53M
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Sentinel Subjects Dosed in Second Cohort of Phase 1 Trial
|
|
Lachietrades
|
9 |
3.0K |
1 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
140K
|
53M
|
5
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
140K
|
53M
|
5
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Acquisition Offers Potential Increase to NAL Resource
|
|
Lachietrades
|
125 |
81K |
2 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
125
|
81K
|
2
|
|
ASX - By Stock
|
SYA |
Re:
2022 AGM- QUESTIONS FOR BRETT
|
|
Lachietrades
|
96 |
40K |
2 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
96
|
40K
|
2
|
|
ASX - By Stock
|
SYA |
Re:
2022 AGM- QUESTIONS FOR BRETT
|
|
Lachietrades
|
96 |
40K |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
96
|
40K
|
0
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
2 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
140K
|
53M
|
2
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Lachietrades
|
140K |
53M |
6 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
140K
|
53M
|
6
|
|
ASX - By Stock
|
PRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Lachietrades
|
13 |
7.2K |
8 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
7.2K
|
8
|
|
ASX - By Stock
|
SYA |
Re:
SYA Chart
|
|
Lachietrades
|
2.3K |
1.2M |
2 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
2.3K
|
1.2M
|
2
|
|
ASX - Day Trading
|
|
Re:
Morning trading November 4
|
|
Lachietrades
|
247 |
48K |
1 |
04/11/22 |
04/11/22 |
ASX - Day Trading
|
247
|
48K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Safety Review Committee Approves Second Cohort
|
|
Lachietrades
|
21 |
5.4K |
1 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
21
|
5.4K
|
1
|
|